v3.26.1
Consolidated Statement of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Cash Flows [Abstract]    
Net loss $ (2,136,469) $ (3,650,451)
(Income)loss from discontinued operations 374,237
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,321 2,321
Amortization of debt discount 13,446 978,721
ROU assets, net (1,510) 1,808
Change in FV of Derivative 3,480
Loss on write-off of investment 250,000
Non-cash share-based compensation 176,972 140,762
Changes in working capital items:    
Accounts receivable, net (4,585) 115,926
Inventory, net (21,384) 27,671
Prepaid expenses and other current assets 48,875 (58,845)
Deposits 5,141 (70,000)
Accounts payable and accrued expenses (102,629) 1,139,917
Accrued interest payable 835,850 190,247
Net cash used in operating activities - continuing operations (930,492) (808,046)
Cash flows from financing activities:    
Proceeds from issuance of Common stock 1,371,976
Proceeds from issuance of debt 881,650
Principal repayment of debt (318,435) (125,840)
Net cash provided by financing activities - continuing operations 1,053,541 755,810
Cash flows from discontinued operations    
Operating cash flows 83,960
Investing cash flows 
Financing cash flows
Net cash provided by (used in) discontinued operations  83,960
Net cash effect of exchange rate changes on cash (23,289) (47,070)
Net change in cash and cash equivalents 99,760 (15,346)
Cash and cash equivalents, beginning of year 281,435 15,346
Cash and cash equivalents, end of period 381,195
Supplemental disclosure of cash flow information:    
Cash paid for Interest 132,863 78,783
Supplemental disclosure of non-cash investing and financing activities    
Notes payable and accrued interest converted to common stock (266,770 shares in 2026 & 224,541 shares in 2025,) 80,000 1,665,953
Non-cash debt discount in the form of issuance of equity instruments in conjunction with convertible notes $ 2,435,082